E-Book | November 28, 2017

How To Prevent Data Integrity Warning Letters

Source: Pharmaceutical Online
How To Prevent Data Integrity Warning Letters

Failures in data governance and data integrity continue to be addressed in approximately 80% of FDA warning letters issued to domestic and foreign sites. This ebook explores insights and strategies from experts in the field, including:

  • An Analysis of FDA Warning Letters
  • Is GMP Quality System Auditing Fundamentally Flawed?
  • Managing GxP Environmental Systems To Ensure Data Integrity
  • 5 Steps To Build A Quality Culture That Supports Data Integrity
  • The 5 Basic Tenets of Data Integrity - And How Failures Occur

access the E-Book!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Pharmaceutical Online? Subscribe today.

Subscribe to Pharmaceutical Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Pharmaceutical Online